These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23358904)

  • 1. Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment.
    Calip GS; Boudreau DM; Loggers ET
    Breast Cancer Res Treat; 2013 Feb; 138(1):225-33. PubMed ID: 23358904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.
    Calip GS; Hubbard RA; Stergachis A; Malone KE; Gralow JR; Boudreau DM
    Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):75-85. PubMed ID: 24923811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.
    Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA
    J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
    Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
    Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
    Kazerooni R; Watanabe JH; Bounthavong M
    Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to statins and LDL-cholesterol goal attainment.
    Chi MD; Vansomphone SS; Liu IL; Cheetham C; Green KR; Scott RD; Reynolds K
    Am J Manag Care; 2014 Apr; 20(4):e105-12. PubMed ID: 24884955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
    Calip GS; Elmore JG; Boudreau DM
    Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
    Khunti K; Danese MD; Kutikova L; Catterick D; Sorio-Vilela F; Gleeson M; Kondapally Seshasai SR; Brownrigg J; Ray KK
    JAMA Netw Open; 2018 Dec; 1(8):e185554. PubMed ID: 30646277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial.
    Barankay I; Reese PP; Putt ME; Russell LB; Loewenstein G; Pagnotti D; Yan J; Zhu J; McGilloway R; Brennan T; Finnerty D; Hoffer K; Chadha S; Volpp KG
    JAMA Netw Open; 2020 Oct; 3(10):e2019429. PubMed ID: 33034639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.
    Pittman DG; Chen W; Bowlin SJ; Foody JM
    Am J Cardiol; 2011 Jun; 107(11):1662-6. PubMed ID: 21439533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence.
    Citarella A; Linder M; Kieler H; Berglind IA; Sundström A; Wettermark B; Andersen M
    Eur J Clin Pharmacol; 2016 Mar; 72(3):349-57. PubMed ID: 26671240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.
    Guglielmi V; Bellia A; Pecchioli S; Della-Morte D; Parretti D; Cricelli I; Medea G; Sbraccia P; Lauro D; Cricelli C; Lapi F
    Atherosclerosis; 2017 Aug; 263():36-41. PubMed ID: 28599257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.
    Chopra I; Dwibedi N; Mattes MD; Tan X; Findley P; Sambamoorthi U
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1351-1360. PubMed ID: 29118227
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study.
    Rezende Macedo do Nascimento RC; Mueller T; Godman B; MacBride Stewart S; Hurding S; de Assis Acurcio F; Guerra Junior AA; Alvares Teodoro J; Morton A; Bennie M; Kurdi A
    Br J Clin Pharmacol; 2020 Dec; 86(12):2349-2361. PubMed ID: 32353163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users.
    Sigglekow F; Horsburgh S; Parkin L
    PLoS One; 2020; 15(11):e0242424. PubMed ID: 33211724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].
    Degli Esposti L; Sangiorgi D; Arca M; Vigna GB; Budal S; Degli Esposti E
    Monaldi Arch Chest Dis; 2011 Dec; 76(4):160-7. PubMed ID: 22567731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.